Holen Sie sich die Stockscreener-App
3.18
0.00%
0.00
Handel nachbörslich:
3.18
Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday - MarketBeat
Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic - MSN
Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest - MarketBeat
Anixa Biosciences director Titterton buys $8,820 in common stock - MSN
Anixa Biosciences (STU:CY71) EV-to-OCF : -12.38 (As of Dec. 28, 2025) - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Anixa Biosciences (FRA:CY71) EV-to-OCF : -12.43 (As of Dec. 22, 2025) - GuruFocus
Why analysts upgrade Anixa Biosciences Inc. stock2025 Risk Factors & Precise Buy Zone Identification - Улправда
Can Anixa Biosciences Inc. stock attract ESG capital inflowsMarket Sentiment Review & Low Drawdown Trading Techniques - Улправда
Is Anixa Biosciences Inc. stock gaining market shareEarnings Recap Report & AI Enhanced Trading Signals - Улправда
Why retail investors pile into Anixa Biosciences Inc. stock2025 Market Overview & Safe Capital Preservation Plans - Улправда
Is Anixa Biosciences Inc. (CY71) stock a buy for dividend portfolios2025 Macro Impact & Fast Exit Strategy with Risk Control - DonanımHaber
ANIX: Phase 1 Breast Cancer Vaccine Success Paves Way for Program Advancement - Smartkarma
Will Anixa Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Selloffs & Capital Protection Trade Alerts - DonanımHaber
Gap Down: Is Anixa Biosciences Inc CY71 stock cheap by valuation metricsNew Guidance & Target Return Focused Stock Picks - moha.gov.vn
What is the fair value of Anixa Biosciences Inc. stock now2025 EndofYear Setup & Fast Gain Swing Alerts - Улправда
How strong is Anixa Biosciences Inc. stock balance sheetWeekly Profit Summary & Growth Focused Stock Pick Reports - Улправда
Aug Action: Why Anixa Biosciences Inc stock could be next big winnerMarket Movers & Fast Momentum Entry Tips - moha.gov.vn
Anixa Biosciences Inc (ANIX) director reports 16,000 share option exercise - Stock Titan
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic - Investing.com Australia
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance
ANIX: Breast cancer vaccine phase I showed 75% robust immune response and strong safety profile - TradingView — Track All Markets
Anixa Biosciences falls on phase 1 data for breast cancer vaccine - MSN
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 - WV News
Cleveland Clinic transfers breast cancer vaccine IND to Anixa - marketscreener.com
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine Developm - GuruFocus
Anixa Biosciences Announces Transfer of IND for Breast Cancer Va - GuruFocus
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic By Investing.com - Investing.com South Africa
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic - Nasdaq
D. Boral Capital Maintains Anixa Biosciences (ANIX) Buy Recommendation - Nasdaq
Anixa Biosciences (ANIX) Shares Drop 21% After Phase 1 Vaccine D - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital - MarketBeat
ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus
Anixa Biosciences Reports Positive Phase 1 Trial Results - TipRanks
Anixa Biosciences Inc Announces Positive Phase 1 Data for Breast Cancer Vaccine - TradingView — Track All Markets
Anixa Biosciences Says Breast Cancer Vaccine Candidate Meets Key Endpoints in Phase 1 Trial - marketscreener.com
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why - Benzinga
Anixa Biosciences Announces Positive Phase 1 Data for Investigat - GuruFocus
Anixa Biosciences (ANIX) Presents Promising Phase 1 Breast Cance - GuruFocus
Anixa Biosciences (NASDAQ: ANIX) presents final Phase 1 breast cancer vaccine data - Stock Titan
Anixa’s breast cancer vaccine shows positive Phase 1 results - Investing.com
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - WV News
Cleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast Cancer Vaccine Study - Cleveland Clinic Newsroom
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) sets Dec. 15 talk on Phase 1 breast cancer vaccine - Stock Titan
Anixa Biosciences (NASDAQ: ANIX) unveils final Phase 1 breast cancer vaccine results at 2025 SABCS - Stock Titan
Will Anixa Biosciences Inc. (CY71) stock beat Nasdaq index returns2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
Why Anixa Biosciences Inc. (CY71) stock is trending on social mediaPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Will Anixa Biosciences Inc. stock see PE expansionWeekly Trading Summary & Risk Controlled Stock Pick Alerts - Newser
Is Anixa Biosciences Inc. stock undervalued vs historical averagesJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Who are in the management team of Anixa Biosciences, Inc.? - Markets Mojo
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):